Coloplast A/S CLPBF
72.55 USD -2.85 (-3.78%)
At closeNov 10, 2026, 4:00 PM EST
75.25 Day range 75.25
56.81 52-week range 95.43
- YTD
- -13.32%
- 1 year
- -22.96%
News
seekingalpha.com Coloplast: Turnaround Is Underway, But Upside Is Limited Coloplast remains a long-term 'Buy' but with limited short-term upside as shares approach intrinsic value. CLPBF's revised mid-term guidance now targets 5–7% organic growth and EBIT margins in the…
reuters.com Coloplast pares back China operations as market recovery remains elusive Coloplast pares back China operations as market recovery remains elusive
reuters.com Coloplast expects Kerecis wound-care unit to return to growth in 2027, CFO says Medical equipment maker Coloplast expects its Kerecis wound-care business to return to growth from January 2027 after changes to U.S. Medicare payments caused sales in outpatient settings to fall…
seekingalpha.com Coloplast Might Have Found Its Bottom Coloplast remains a 'Buy,' trading ~20% below intrinsic value despite recent struggles and special charges. Organic growth was 6% in Q2-25/26, but reported results were impacted by a DKK 3 billion…
seekingalpha.com Coloplast: Went 'BUY' A Bit Early Coloplast is rebased to a 20x P/E with a new price target of 490 DKK, reflecting a more realistic valuation post-premiumization. Recent setbacks—the Kerecis acquisition write-down, product recalls,…
seekingalpha.com Coloplast A/S (CLPBY) Q2 2026 Earnings Call Transcript Coloplast A/S (CLPBY) Q2 2026 Earnings Call Transcript
seekingalpha.com Coloplast: The Market Is Throwing Away A High-Quality Compounder Coloplast is now a clear Buy, trading nearly 60% below its all-time high and at historically low valuation multiples. CLPBF's wide economic moat, underpinned by patents and high switching costs,…
globenewswire.com Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons.
globenewswire.com Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons
globenewswire.com Coloplast appoints Gavin Wood as new CEO Announcement no. 3/2026 Inside information Coloplast appoints Gavin Wood as new CEO The Coloplast Board of Directors is pleased to announce the appointment of Gavin Wood as the new President and…
globenewswire.com Coloplast A/S - Updated Financial Calendar 2025-26 Please see enclosed pdf. Update to Financial Calendar Dates Coloplast has updated the dates in its financial calendar for the publication of the FY Financial Statements 2025/26 and the Annual General…
seekingalpha.com Coloplast A/S (CLPBY) Q1 2026 Earnings Call Transcript Coloplast A/S (CLPBY) Q1 2026 Earnings Call Transcript
globenewswire.com Coloplast A/S - Interim Financial Report, Q1 2025/26 2025/26Interim financial results, Q1 2025/261 October 2025 - 31 December 2025 Coloplast delivered Q1 organic growth of 6% and EBIT growth1 in constant currencies of 3%. Reported revenue in DKK grew…- globenewswire.com Coloplast A/S - Interim Financial Report, Q1 2025/26 2025/26Interim financial results, Q1 2025/261 October 2025 - 31 December 2025 Coloplast delivered Q1 organic growth of 6% and EBIT growth1 in constant currencies of 3%. Reported revenue in DKK grew…
globenewswire.com Coloplast announces changes to Executive Leadership Team Today, Coloplast is announcing changes to the company's Executive Leadership Team (ELT). The changes relate to the company's Interventional Urology business as well as the global People & Culture…
seekingalpha.com Coloplast A/S (CLPBY) Shareholder/Analyst Call Transcript Coloplast A/S (CLPBY) Shareholder/Analyst Call Transcript
globenewswire.com Coloplast A/S - Decisions at the Annual General Meeting 2025 Today, 4 December 2025, Coloplast A/S held its Annual General Meeting, at which the following resolutions were adopted: The annual report for the financial year 2024/25 was approved. Distribution of…
seekingalpha.com Coloplast A/S (CLPBY) Q4 2025 Earnings Call Transcript Coloplast A/S (OTCPK:CLPBY) Q4 2025 Earnings Call November 4, 2025 5:00 AM EST Company Participants Lars Rasmussen Anders Lonning-Skovgaard - Executive VP & CFO Conference Call Participants Hassan…
seekingalpha.com After A 50% Decline, Coloplast Might Finally Be Worth Buying Coloplast is now rated a cautious 'Buy,' as its valuation has become more reasonable after a significant price correction. Coloplast continues to deliver solid organic growth, boasts a wide economic…
globenewswire.com Coloplast interim CEO Lars Rasmussen will step down from the Board at the upcoming Annual General Meeting Announcement no. 09/2025Inside information Coloplast interim CEO Lars Rasmussen will step down from the Board at the upcoming Annual General Meeting Coloplast interim CEO Lars Rasmussen has today…
benzinga.com Stocks That Hit 52-Week Highs On Tuesday 
benzinga.com Stocks That Hit 52-Week Highs On Wednesday 
benzinga.com Stocks That Hit 52-Week Highs On Tuesday 
benzinga.com Stocks That Hit 52-Week Highs On Friday - benzinga.com Stocks That Hit 52-Week Highs On Monday